NfL as a biomarker for neurodegeneration and survival in Parkinson
Por um escritor misterioso
Descrição
Neurofilament Light as a Dementia Biomarker - Practical Neurology
NfL as a biomarker for neurodegeneration and survival in Parkinson
Neurofilament light chain is increased in the parahippocampal
Frontiers Neurofilament light as a biomarker for motor decline
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as
Opinion: The Potential of Neurofilament Light Chain as a Biomarker
Blood NfL Neurology
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as
Cells, Free Full-Text
CSF Neurofilament light (NfL) protein levels in patients with
Serum Neurofilament Light Chain as a Marker of Progression in
Serum neurofilament light levels are predictive of all-cause
NfL as a biomarker for neurodegeneration and survival in Parkinson
Regional free-water differentially associated with glial
de
por adulto (o preço varia de acordo com o tamanho do grupo)
